| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,916 |
13,291 |
$722K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,688 |
8,216 |
$638K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,844 |
1,742 |
$62K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
641 |
635 |
$50K |
| 99215 |
Prolong outpt/office vis |
353 |
340 |
$47K |
| 36415 |
Collection of venous blood by venipuncture |
5,988 |
5,741 |
$24K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
620 |
616 |
$15K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
413 |
412 |
$11K |
| 0001A |
|
310 |
310 |
$6K |
| 92551 |
|
621 |
618 |
$4K |
| 99201 |
|
102 |
95 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
36 |
36 |
$3K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,195 |
1,184 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
310 |
298 |
$3K |
| 90686 |
|
382 |
370 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
29 |
29 |
$2K |
| 0002A |
|
150 |
149 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
25 |
24 |
$2K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
50 |
48 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
16 |
16 |
$1K |
| 99402 |
|
18 |
18 |
$861.48 |
| 90691 |
|
14 |
14 |
$829.78 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$698.31 |
| 99173 |
|
526 |
524 |
$679.56 |
| 99188 |
|
74 |
74 |
$511.90 |
| 0124A |
|
13 |
12 |
$416.09 |
| 96127 |
|
87 |
87 |
$351.75 |
| 81001 |
|
29 |
28 |
$4.07 |
| X5622 |
|
253 |
252 |
$0.00 |
| 81025 |
|
26 |
26 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
178 |
172 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
33 |
32 |
$0.00 |
| 91300 |
|
21 |
19 |
$0.00 |
| 80061 |
Lipid panel |
27 |
27 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
35 |
34 |
$0.00 |
| 87210 |
|
15 |
15 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
25 |
25 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
32 |
31 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
84 |
80 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
13 |
$0.00 |
| 87081 |
|
48 |
45 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
13 |
$0.00 |